Charles M Perou - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Charles M Perou

Showing results (221-230 of 447) with videos related to

Pageof 45

Sort By:

BMC Medicine|March 18, 2009

A compact VEGF signature associated with distant metastases and poor outcomesZhiyuan Hu, Cheng Fan, Chad Livasy, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 24, 2011

Defining the cellular precursors to human breast cancerPatricia J Keller, Lisa M Arendt, Adam Skibinski, et al.

Breast Cancer Research and Treatment|December 11, 2012

MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasionJessica Bockhorn, Kathy Yee, Ya-Fang Chang, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 3, 2011

Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cellsJason I Herschkowitz, Wei Zhao, Mei Zhang, et al.

Journal of the National Cancer Institute|May 14, 2009

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancerMaggie C U Cheang, Stephen K Chia, David Voduc, et al.

Biorxiv : the Preprint Server for Biology|April 8, 2024

Generative Adversarial Networks Accurately Reconstruct Pan-Cancer Histology from Pathologic, Genomic, and Radiographic Latent FeaturesFrederick M Howard, Hanna M Hieromnimon, Siddhi Ramesh, et al.

Science Advances|November 15, 2024

Generative adversarial networks accurately reconstruct pan-cancer histology from pathologic, genomic, and radiographic latent featuresFrederick M Howard, Hanna M Hieromnimon, Siddhi Ramesh, et al.

NPJ Breast Cancer|March 8, 2025

Prognostic and molecular multi-platform analysis of CALGB 40603 (Alliance) and public triple-negative breast cancer datasetsBrooke M Felsheim, Aranzazu Fernandez-Martinez, Cheng Fan, et al.

Journal of the National Cancer Institute|April 5, 2017

Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin ResponsivenessPaola A Rojas, María May, Gonzalo R Sequeira, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 14, 2013

Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapiesAriella B Hanker, Adam D Pfefferle, Justin M Balko, et al.

Pageof 45

Search research articles

Showing results (221-230 of 447) with videos related to

Sort By:

Pageof 45

BMC Medicine|March 18, 2009

A compact VEGF signature associated with distant metastases and poor outcomesZhiyuan Hu, Cheng Fan, Chad Livasy, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 24, 2011

Defining the cellular precursors to human breast cancerPatricia J Keller, Lisa M Arendt, Adam Skibinski, et al.

Breast Cancer Research and Treatment|December 11, 2012

MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasionJessica Bockhorn, Kathy Yee, Ya-Fang Chang, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 3, 2011

Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cellsJason I Herschkowitz, Wei Zhao, Mei Zhang, et al.

Journal of the National Cancer Institute|May 14, 2009

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancerMaggie C U Cheang, Stephen K Chia, David Voduc, et al.

Biorxiv : the Preprint Server for Biology|April 8, 2024

Generative Adversarial Networks Accurately Reconstruct Pan-Cancer Histology from Pathologic, Genomic, and Radiographic Latent FeaturesFrederick M Howard, Hanna M Hieromnimon, Siddhi Ramesh, et al.

Science Advances|November 15, 2024

Generative adversarial networks accurately reconstruct pan-cancer histology from pathologic, genomic, and radiographic latent featuresFrederick M Howard, Hanna M Hieromnimon, Siddhi Ramesh, et al.

NPJ Breast Cancer|March 8, 2025

Prognostic and molecular multi-platform analysis of CALGB 40603 (Alliance) and public triple-negative breast cancer datasetsBrooke M Felsheim, Aranzazu Fernandez-Martinez, Cheng Fan, et al.

Journal of the National Cancer Institute|April 5, 2017

Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin ResponsivenessPaola A Rojas, María May, Gonzalo R Sequeira, et al.

Proceedings of the National Academy of Sciences of the United States of America|August 14, 2013

Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapiesAriella B Hanker, Adam D Pfefferle, Justin M Balko, et al.

Pageof 45